Definitive Contract HHSN261201400006C

The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...

This federal contract award to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard) provides DNA characterization services to support the genomic research initiatives of several National Cancer Institute (NCI) programs, including the Cancer Genome Characterization Center, Clinical Proteomic Tumor Analysis Consortium, and Division of Cancer Epidemiology and Genetics. The $19,570,872.26 firm-fixed-price delivery order was issued under the NCI Genomic Characterization...

This SBIR Phase I contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Navipoint Genomics LLC, a minority-owned and Asian-Pacific American-owned limited liability company. The $251,927 firm-fixed-price contract is for the development of cloud-based software in support of the Cancer Research Data Commons. This contract was issued under the total small business set-aside NIH SBIR solicitation PHS-2020-1, which...

This is a delivery order contract awarded by the National Cancer Institute (NCI) to The Broad Institute, Inc. for DNA whole genome sequencing (WGS) services in support of new CCG (Chronic Condition Genomics) studies. The contract has a period of performance from September 1, 2020 to August 31, 2023, with a total ceiling value of $2,677,314.06. This delivery order is part of the larger NCI Genomic Characterization Centers contract vehicle, which provides advanced genomic research and sequencing...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $455,000.00 Firm Fixed Price Definitive Contract to Omicscraft LLC, a minority-owned, small disadvantaged business, for a cloud-based liquid-biopsy platform to support the Cancer Research Data Commons. This contract falls under the ISYSMET program, which focuses on the development of cloud-based pipelines for integrative analysis of multi-omics and imaging data. The...

This contract was awarded by the Air Mobility Command, a defense agency within the U.S. Department of the Air Force, to Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory headquartered in Fort Myers, Florida. The contract, valued at $977,826.00, is for the provision of anatomic pathology services in accordance with the performance work statement (PWS) at the David Grant Medical Center, Travis Air Force Base in Fairfield, California. The services include...

This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...

The Centers for Disease Control and Prevention (CDC) awarded a $716,320 purchase order to Theiagen Consulting LLC, doing business as Theiagen Genomics, for TERRA SUPPORT under its major program code for Communicable Disease. Theiagen Genomics will provide genomics support services from its location in Highlands Ranch, Colorado to the CDC in Pittsburgh, Pennsylvania over the one-year period beginning September 8, 2021 through August 14, 2022. The contract utilizes firm fixed pricing for the...

This is a delivery order issued under the National Cancer Institute's (NCI) Genomic Characterization Center Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The prime contractor is The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a renowned biomedical and genomic research organization. The contract has a ceiling value of $3,890,489.86 and a period of performance through September 9, 2026. The contract supports the NCI Genomic Characterization Centers...